APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prophylactic Gamma Globulin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prophylactic Gamma Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174029060322 December 2025198 pages

Choose your research edition.

Industry ResearchProphylactic Gamma Globulin Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Prophylactic Gamma Globulin Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Prophylactic Gamma Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prophylactic Gamma Globulin Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Prophylactic Gamma Globulin Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Prophylactic Gamma Globulin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prophylactic Gamma Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prophylactic Gamma Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prophylactic Gamma Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prophylactic Gamma Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prophylactic Gamma Globulin include CNBG, Takeda, Shenzhen Weiguang Biological, Beijing Tiantan Biological, CBPO, Sichuan Yuanda Shuyang, Shanghai RAAS, Pacific Shuanglin Bio-pharmacy and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prophylactic Gamma Globulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prophylactic Gamma Globulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prophylactic Gamma Globulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prophylactic Gamma Globulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Prophylactic Gamma Globulin Segment by Company

CNBG

Takeda

Shenzhen Weiguang Biological

Beijing Tiantan Biological

CBPO

Sichuan Yuanda Shuyang

Shanghai RAAS

Pacific Shuanglin Bio-pharmacy

Grifols

Hualan Biological

Beijing Bohui Innovation Biotechnology

Baxter

Octapharma

LFB Group

Kedrion Biopharma

BPL

Biotest

ADMA Biologics

Prophylactic Gamma Globulin Segment by Type

IVIg Liquid

IVIg Powder

Prophylactic Gamma Globulin Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Prophylactic Gamma Globulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prophylactic Gamma Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prophylactic Gamma Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prophylactic Gamma Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prophylactic Gamma Globulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prophylactic Gamma Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prophylactic Gamma Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prophylactic Gamma Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prophylactic Gamma Globulin Industry Trends Table 2. Prophylactic Gamma Globulin Industry Drivers Table 3. Prophylactic Gamma Globulin Industry Opportunities and Challenges Table 4. Prophylactic Gamma Globulin Industry Restraints Table 5. Global Prophylactic Gamma Globulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prophylactic Gamma Globulin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prophylactic Gamma Globulin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Prophylactic Gamma Globulin Sales Market Share by Manufacturers Table 9. Global Prophylactic Gamma Globulin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Prophylactic Gamma Globulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prophylactic Gamma Globulin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prophylactic Gamma Globulin Manufacturers, Product Type & Application Table 13. Global Prophylactic Gamma Globulin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prophylactic Gamma Globulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of IVIg Liquid Table 17. Major Manufacturers of IVIg Powder Table 18. Global Prophylactic Gamma Globulin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Prophylactic Gamma Globulin Sales by Type (2021-2026) & (k units) Table 20. Global Prophylactic Gamma Globulin Sales by Type (2027-2032) & (k units) Table 21. Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2026) Table 22. Global Prophylactic Gamma Globulin Sales Market Share by Type (2027-2032) Table 23. Global Prophylactic Gamma Globulin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Prophylactic Gamma Globulin Revenue by Type (2021-2026) & (k units) Table 25. Global Prophylactic Gamma Globulin Revenue by Type (2027-2032) & (k units) Table 26. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2026) Table 27. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Autoimmune Disease Table 29. Major Manufacturers of Immunodeficiency Table 30. Major Manufacturers of Acute Infection Table 31. Global Prophylactic Gamma Globulin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Prophylactic Gamma Globulin Sales by Application (2021-2026) & (k units) Table 33. Global Prophylactic Gamma Globulin Sales by Application (2027-2032) & (k units) Table 34. Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2026) Table 35. Global Prophylactic Gamma Globulin Sales Market Share by Application (2027-2032) Table 36. Global Prophylactic Gamma Globulin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Prophylactic Gamma Globulin Revenue by Application (2021-2026) & (k units) Table 38. Global Prophylactic Gamma Globulin Revenue by Application (2027-2032) & (k units) Table 39. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2026) Table 40. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2027-2032) Table 41. Global Prophylactic Gamma Globulin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Prophylactic Gamma Globulin Sales by Region (2021-2026) & (k units) Table 43. Global Prophylactic Gamma Globulin Sales Market Share by Region (2021-2026) Table 44. Global Prophylactic Gamma Globulin Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Prophylactic Gamma Globulin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Prophylactic Gamma Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 48. North America Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 49. Europe Prophylactic Gamma Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 51. Europe Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Prophylactic Gamma Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Prophylactic Gamma Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 58. Global Prophylactic Gamma Globulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Prophylactic Gamma Globulin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Prophylactic Gamma Globulin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2021-2026) Table 62. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2027-2032) Table 63. CNBG Company Information Table 64. CNBG Business Overview Table 65. CNBG Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. CNBG Prophylactic Gamma Globulin Product Portfolio Table 67. CNBG Recent Development Table 68. Takeda Company Information Table 69. Takeda Business Overview Table 70. Takeda Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Takeda Prophylactic Gamma Globulin Product Portfolio Table 72. Takeda Recent Development Table 73. Shenzhen Weiguang Biological Company Information Table 74. Shenzhen Weiguang Biological Business Overview Table 75. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio Table 77. Shenzhen Weiguang Biological Recent Development Table 78. Beijing Tiantan Biological Company Information Table 79. Beijing Tiantan Biological Business Overview Table 80. Beijing Tiantan Biological Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio Table 82. Beijing Tiantan Biological Recent Development Table 83. CBPO Company Information Table 84. CBPO Business Overview Table 85. CBPO Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CBPO Prophylactic Gamma Globulin Product Portfolio Table 87. CBPO Recent Development Table 88. Sichuan Yuanda Shuyang Company Information Table 89. Sichuan Yuanda Shuyang Business Overview Table 90. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio Table 92. Sichuan Yuanda Shuyang Recent Development Table 93. Shanghai RAAS Company Information Table 94. Shanghai RAAS Business Overview Table 95. Shanghai RAAS Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio Table 97. Shanghai RAAS Recent Development Table 98. Pacific Shuanglin Bio-pharmacy Company Information Table 99. Pacific Shuanglin Bio-pharmacy Business Overview Table 100. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio Table 102. Pacific Shuanglin Bio-pharmacy Recent Development Table 103. Grifols Company Information Table 104. Grifols Business Overview Table 105. Grifols Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Grifols Prophylactic Gamma Globulin Product Portfolio Table 107. Grifols Recent Development Table 108. Hualan Biological Company Information Table 109. Hualan Biological Business Overview Table 110. Hualan Biological Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hualan Biological Prophylactic Gamma Globulin Product Portfolio Table 112. Hualan Biological Recent Development Table 113. Beijing Bohui Innovation Biotechnology Company Information Table 114. Beijing Bohui Innovation Biotechnology Business Overview Table 115. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio Table 117. Beijing Bohui Innovation Biotechnology Recent Development Table 118. Baxter Company Information Table 119. Baxter Business Overview Table 120. Baxter Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Baxter Prophylactic Gamma Globulin Product Portfolio Table 122. Baxter Recent Development Table 123. Octapharma Company Information Table 124. Octapharma Business Overview Table 125. Octapharma Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Octapharma Prophylactic Gamma Globulin Product Portfolio Table 127. Octapharma Recent Development Table 128. LFB Group Company Information Table 129. LFB Group Business Overview Table 130. LFB Group Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. LFB Group Prophylactic Gamma Globulin Product Portfolio Table 132. LFB Group Recent Development Table 133. Kedrion Biopharma Company Information Table 134. Kedrion Biopharma Business Overview Table 135. Kedrion Biopharma Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio Table 137. Kedrion Biopharma Recent Development Table 138. BPL Company Information Table 139. BPL Business Overview Table 140. BPL Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. BPL Prophylactic Gamma Globulin Product Portfolio Table 142. BPL Recent Development Table 143. Biotest Company Information Table 144. Biotest Business Overview Table 145. Biotest Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Biotest Prophylactic Gamma Globulin Product Portfolio Table 147. Biotest Recent Development Table 148. ADMA Biologics Company Information Table 149. ADMA Biologics Business Overview Table 150. ADMA Biologics Prophylactic Gamma Globulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. ADMA Biologics Prophylactic Gamma Globulin Product Portfolio Table 152. ADMA Biologics Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Prophylactic Gamma Globulin Distributors List Table 156. Prophylactic Gamma Globulin Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Prophylactic Gamma Globulin Product Image Figure 2. Global Prophylactic Gamma Globulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prophylactic Gamma Globulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Prophylactic Gamma Globulin Sales (2021-2032) & (k units) Figure 5. Global Prophylactic Gamma Globulin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prophylactic Gamma Globulin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. IVIg Liquid Image Figure 9. IVIg Powder Image Figure 10. Global Prophylactic Gamma Globulin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Prophylactic Gamma Globulin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2032) Figure 13. Global Prophylactic Gamma Globulin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Prophylactic Gamma Globulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2032) Figure 16. Autoimmune Disease Image Figure 17. Immunodeficiency Image Figure 18. Acute Infection Image Figure 19. Global Prophylactic Gamma Globulin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Prophylactic Gamma Globulin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2032) Figure 22. Global Prophylactic Gamma Globulin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Prophylactic Gamma Globulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2032) Figure 25. North America Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 27. U.S. Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 32. Germany Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 39. China Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Prophylactic Gamma Globulin Sales Market Share by Country (2021-2032) Figure 47. Brazil Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Prophylactic Gamma Globulin Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Prophylactic Gamma Globulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Prophylactic Gamma Globulin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Figure 58. North America Prophylactic Gamma Globulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Prophylactic Gamma Globulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Prophylactic Gamma Globulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Prophylactic Gamma Globulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Prophylactic Gamma Globulin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Prophylactic Gamma Globulin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • CNBG
  • Takeda
  • Shenzhen Weiguang Biological
  • Beijing Tiantan Biological
  • CBPO
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Pacific Shuanglin Bio-pharmacy
  • Grifols
  • Hualan Biological
  • Beijing Bohui Innovation Biotechnology
  • Baxter
  • Octapharma
  • LFB Group
  • Kedrion Biopharma
  • BPL
  • Biotest
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prophylactic Gamma Globulin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prophylactic Gamma Globulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prophylactic Gamma Globulin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prophylactic Gamma Globulin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prophylactic Gamma Globulin Market Dynamics
  1. 2.1 Prophylactic Gamma Globulin Industry Trends
  2. 2.2 Prophylactic Gamma Globulin Industry Drivers
  3. 2.3 Prophylactic Gamma Globulin Industry Opportunities and Challenges
  4. 2.4 Prophylactic Gamma Globulin Industry Restraints
3 Prophylactic Gamma Globulin Market by Manufacturers
  1. 3.1 Global Prophylactic Gamma Globulin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prophylactic Gamma Globulin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prophylactic Gamma Globulin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prophylactic Gamma Globulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prophylactic Gamma Globulin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prophylactic Gamma Globulin Manufacturers, Product Type & Application
  7. 3.7 Global Prophylactic Gamma Globulin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prophylactic Gamma Globulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prophylactic Gamma Globulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prophylactic Gamma Globulin Tier 1, Tier 2, and Tier 3
4 Prophylactic Gamma Globulin Market by Type
  1. 4.1 Prophylactic Gamma Globulin Type Introduction
  2. 4.1.1 IVIg Liquid
  3. 4.1.2 IVIg Powder
  4. 4.2 Global Prophylactic Gamma Globulin Sales by Type
  5. 4.2.1 Global Prophylactic Gamma Globulin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Prophylactic Gamma Globulin Sales by Type (2021-2032)
  7. 4.2.3 Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Prophylactic Gamma Globulin Revenue by Type
  9. 4.3.1 Global Prophylactic Gamma Globulin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Prophylactic Gamma Globulin Revenue by Type (2021-2032)
  11. 4.3.3 Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2032)
5 Prophylactic Gamma Globulin Market by Application
  1. 5.1 Prophylactic Gamma Globulin Application Introduction
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global Prophylactic Gamma Globulin Sales by Application
  6. 5.2.1 Global Prophylactic Gamma Globulin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prophylactic Gamma Globulin Sales by Application (2021-2032)
  8. 5.2.3 Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Prophylactic Gamma Globulin Revenue by Application
  10. 5.3.1 Global Prophylactic Gamma Globulin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prophylactic Gamma Globulin Revenue by Application (2021-2032)
  12. 5.3.3 Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2032)
6 Global Prophylactic Gamma Globulin Sales by Region
  1. 6.1 Global Prophylactic Gamma Globulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prophylactic Gamma Globulin Sales by Region (2021-2032)
  3. 6.2.1 Global Prophylactic Gamma Globulin Sales by Region (2021-2026)
  4. 6.2.2 Global Prophylactic Gamma Globulin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prophylactic Gamma Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prophylactic Gamma Globulin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prophylactic Gamma Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prophylactic Gamma Globulin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prophylactic Gamma Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prophylactic Gamma Globulin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prophylactic Gamma Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prophylactic Gamma Globulin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prophylactic Gamma Globulin Revenue by Region
  1. 7.1 Global Prophylactic Gamma Globulin Revenue by Region
  2. 7.1.1 Global Prophylactic Gamma Globulin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prophylactic Gamma Globulin Revenue by Region (2021-2026)
  4. 7.1.3 Global Prophylactic Gamma Globulin Revenue by Region (2027-2032)
  5. 7.1.4 Global Prophylactic Gamma Globulin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prophylactic Gamma Globulin Revenue (2021-2032)
  8. 7.2.2 North America Prophylactic Gamma Globulin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prophylactic Gamma Globulin Revenue (2021-2032)
  11. 7.3.2 Europe Prophylactic Gamma Globulin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prophylactic Gamma Globulin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prophylactic Gamma Globulin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prophylactic Gamma Globulin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prophylactic Gamma Globulin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CNBG
  2. 8.1.1 CNBG Company Information
  3. 8.1.2 CNBG Business Overview
  4. 8.1.3 CNBG Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CNBG Prophylactic Gamma Globulin Product Portfolio
  6. 8.1.5 CNBG Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Prophylactic Gamma Globulin Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Shenzhen Weiguang Biological
  14. 8.3.1 Shenzhen Weiguang Biological Company Information
  15. 8.3.2 Shenzhen Weiguang Biological Business Overview
  16. 8.3.3 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio
  18. 8.3.5 Shenzhen Weiguang Biological Recent Developments
  19. 8.4 Beijing Tiantan Biological
  20. 8.4.1 Beijing Tiantan Biological Company Information
  21. 8.4.2 Beijing Tiantan Biological Business Overview
  22. 8.4.3 Beijing Tiantan Biological Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio
  24. 8.4.5 Beijing Tiantan Biological Recent Developments
  25. 8.5 CBPO
  26. 8.5.1 CBPO Company Information
  27. 8.5.2 CBPO Business Overview
  28. 8.5.3 CBPO Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CBPO Prophylactic Gamma Globulin Product Portfolio
  30. 8.5.5 CBPO Recent Developments
  31. 8.6 Sichuan Yuanda Shuyang
  32. 8.6.1 Sichuan Yuanda Shuyang Company Information
  33. 8.6.2 Sichuan Yuanda Shuyang Business Overview
  34. 8.6.3 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio
  36. 8.6.5 Sichuan Yuanda Shuyang Recent Developments
  37. 8.7 Shanghai RAAS
  38. 8.7.1 Shanghai RAAS Company Information
  39. 8.7.2 Shanghai RAAS Business Overview
  40. 8.7.3 Shanghai RAAS Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio
  42. 8.7.5 Shanghai RAAS Recent Developments
  43. 8.8 Pacific Shuanglin Bio-pharmacy
  44. 8.8.1 Pacific Shuanglin Bio-pharmacy Company Information
  45. 8.8.2 Pacific Shuanglin Bio-pharmacy Business Overview
  46. 8.8.3 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio
  48. 8.8.5 Pacific Shuanglin Bio-pharmacy Recent Developments
  49. 8.9 Grifols
  50. 8.9.1 Grifols Company Information
  51. 8.9.2 Grifols Business Overview
  52. 8.9.3 Grifols Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Grifols Prophylactic Gamma Globulin Product Portfolio
  54. 8.9.5 Grifols Recent Developments
  55. 8.10 Hualan Biological
  56. 8.10.1 Hualan Biological Company Information
  57. 8.10.2 Hualan Biological Business Overview
  58. 8.10.3 Hualan Biological Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hualan Biological Prophylactic Gamma Globulin Product Portfolio
  60. 8.10.5 Hualan Biological Recent Developments
  61. 8.11 Beijing Bohui Innovation Biotechnology
  62. 8.11.1 Beijing Bohui Innovation Biotechnology Company Information
  63. 8.11.2 Beijing Bohui Innovation Biotechnology Business Overview
  64. 8.11.3 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio
  66. 8.11.5 Beijing Bohui Innovation Biotechnology Recent Developments
  67. 8.12 Baxter
  68. 8.12.1 Baxter Company Information
  69. 8.12.2 Baxter Business Overview
  70. 8.12.3 Baxter Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Baxter Prophylactic Gamma Globulin Product Portfolio
  72. 8.12.5 Baxter Recent Developments
  73. 8.13 Octapharma
  74. 8.13.1 Octapharma Company Information
  75. 8.13.2 Octapharma Business Overview
  76. 8.13.3 Octapharma Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Octapharma Prophylactic Gamma Globulin Product Portfolio
  78. 8.13.5 Octapharma Recent Developments
  79. 8.14 LFB Group
  80. 8.14.1 LFB Group Company Information
  81. 8.14.2 LFB Group Business Overview
  82. 8.14.3 LFB Group Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 LFB Group Prophylactic Gamma Globulin Product Portfolio
  84. 8.14.5 LFB Group Recent Developments
  85. 8.15 Kedrion Biopharma
  86. 8.15.1 Kedrion Biopharma Company Information
  87. 8.15.2 Kedrion Biopharma Business Overview
  88. 8.15.3 Kedrion Biopharma Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio
  90. 8.15.5 Kedrion Biopharma Recent Developments
  91. 8.16 BPL
  92. 8.16.1 BPL Company Information
  93. 8.16.2 BPL Business Overview
  94. 8.16.3 BPL Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BPL Prophylactic Gamma Globulin Product Portfolio
  96. 8.16.5 BPL Recent Developments
  97. 8.17 Biotest
  98. 8.17.1 Biotest Company Information
  99. 8.17.2 Biotest Business Overview
  100. 8.17.3 Biotest Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biotest Prophylactic Gamma Globulin Product Portfolio
  102. 8.17.5 Biotest Recent Developments
  103. 8.18 ADMA Biologics
  104. 8.18.1 ADMA Biologics Company Information
  105. 8.18.2 ADMA Biologics Business Overview
  106. 8.18.3 ADMA Biologics Prophylactic Gamma Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ADMA Biologics Prophylactic Gamma Globulin Product Portfolio
  108. 8.18.5 ADMA Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prophylactic Gamma Globulin Value Chain Analysis
  2. 9.1.1 Prophylactic Gamma Globulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prophylactic Gamma Globulin Production Mode & Process
  6. 9.2 Prophylactic Gamma Globulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prophylactic Gamma Globulin Distributors
  9. 9.2.3 Prophylactic Gamma Globulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst